BLAKE, JAMES F.,DELISLE, ROBERT KIRK,DE MEESE, LISA A.,GRAHAM, JAMES M.,LE HEUROU, YVAN,LYON, MICHAEL,ROBINSON, JOHN E.,WALLACE, ELI M.,WANG, BIN,XU, RUI
申请号：
TW101106629
公开号：
TW201245193A
申请日:
2012.02.29
申请国别(地区):
TW
年份:
2012
代理人:
摘要：
Compounds of Formula I: in which R1, R2, R3, R4 and R10 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.
